- Report
- October 2019
- 380 Pages
Global
From €4299EUR$4,499USD£3,658GBP
- Report
- April 2023
- 52 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- May 2022
- 45 Pages
Global
From €5734EUR$6,000USD£4,879GBP
- Report
- January 2021
- 43 Pages
Global
From €5256EUR$5,500USD£4,472GBP
From €5734EUR$6,000USD£4,879GBP
- Report
- January 2022
- 176 Pages
Global
From €4586EUR$4,799USD£3,902GBP
- Report
- April 2023
- 206 Pages
Global
From €6689EUR$7,000USD£5,692GBP
- Report
- May 2018
- 140 Pages
Global
From €3345EUR$3,500USD£2,846GBP
- Report
- March 2019
- 99 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- March 2022
- 109 Pages
Global
From €908EUR$950USD£772GBP
- Report
- October 2021
- 112 Pages
Global
From €1147EUR$1,200USD£976GBP
- Report
- November 2021
- 255 Pages
Global
From €2628EUR$2,750USD£2,236GBP
€5256EUR$5,500USD£4,472GBP
- Report
- October 2021
- 55 Pages
Global
From €1887EUR$1,975USD£1,606GBP
€3775EUR$3,950USD£3,212GBP
- Report
- September 2019
- 399 Pages
Global
From €1314EUR$1,375USD£1,118GBP
€2628EUR$2,750USD£2,236GBP
- Report
- February 2018
- 192 Pages
Global
From €597EUR$625USD£508GBP
€1195EUR$1,250USD£1,016GBP
- Report
- September 2022
- 62 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- May 2023
- 220 Pages
Global
From €3345EUR$3,500USD£2,846GBP
- Report
- May 2022
- 51 Pages
Global
From €2341EUR$2,450USD£1,992GBP
- Report
- August 2022
- 72 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- November 2021
- 73 Pages
Global
From €4730EUR$4,950USD£4,025GBP
The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more